387 U.S. 136 (1967)
Abbott Laboratories v. Gardner is a landmark Supreme Court case that addresses the issue of pre-enforcement review of administrative regulations.
Can regulated parties seek pre-enforcement judicial review of administrative regulations?
The Supreme Court held that regulated parties may seek pre-enforcement judicial review of administrative regulations under certain circumstances. The Court established that if a regulation imposes significant burdens on a party and the party has no other adequate means of challenging the regulation, then pre-enforcement review is appropriate. This ruling is grounded in the need to protect parties from irreparable harm that could result from compliance with a regulation that may ultimately be found invalid.
The Supreme Court ruled in favor of Abbott Laboratories, allowing for pre-enforcement judicial review of the FDA's regulation. The Court reasoned that the companies had demonstrated sufficient grounds for seeking review before the regulation was enforced, as the potential harm from compliance could be significant and irreparable. The decision underscored the importance of judicial oversight in administrative actions and affirmed the right of regulated entities to challenge regulations that they believe exceed statutory authority.
Abbott Laboratories v. Gardner is a foundational case in administrative law that has influenced subsequent decisions regarding the timing and scope of judicial review of agency regulations. The ruling established a precedent that allows regulated parties to challenge potentially harmful regulations before they are enforced, thereby safeguarding their rights and interests. This case has been cited in numerous subsequent cases and has shaped the legal landscape surrounding administrative procedures and judicial review.